ELAN CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 927 JPY | -4.43% |
|
+0.87% | -16.94% |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 59% by 2026.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -16.94% | 375M | - | ||
| -28.75% | 70.3B | B- | ||
| +2.04% | 27.46B | C+ | ||
| -6.19% | 17.8B | B | ||
| +2.32% | 17.46B | A- | ||
| +2.10% | 15.46B | A- | ||
| +7.06% | 13.49B | B- | ||
| +10.80% | 13.06B | A- | ||
| +71.31% | 12.96B | C- | ||
| +75.96% | 12.56B | C+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 6099 Stock
- Ratings Elan Corporation